These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31519570)

  • 1. Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human
    Ito A; Nakanishi H; Yoshimura M; Ito S; Sakao Y; Kodera Y; Yatabe Y; Kaneda N
    Anticancer Res; 2019 Sep; 39(9):4711-4720. PubMed ID: 31519570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance.
    Li Y; Zhang X; Liu D; Gong J; Wang DD; Li S; Peng Z; Li Y; Wang X; Lin PP; Li M; Shen L
    Clin Cancer Res; 2018 Nov; 24(21):5261-5271. PubMed ID: 30012565
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.
    Adachi Y; Yoshimura M; Nishida K; Usuki H; Shibata K; Hattori M; Kondo N; Yatabe Y; Iwata H; Kikumori T; Kodera Y; Nakanishi H
    Breast Cancer Res Treat; 2018 Jan; 167(2):439-450. PubMed ID: 29027049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer.
    Matsushita D; Uenosono Y; Arigami T; Yanagita S; Okubo K; Kijima T; Miyazono F; Hamanoue M; Hokita S; Nakashima S; Ohtsuka T; Natsugoe S
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):789-797. PubMed ID: 33641065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients.
    Zhang S; Li L; Wang T; Bian L; Hu H; Xu C; Liu B; Liu Y; Cristofanilli M; Jiang Z
    BMC Cancer; 2016 Jul; 16():526. PubMed ID: 27456503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer.
    Li Y; Zhang X; Ge S; Gao J; Gong J; Lu M; Zhang Q; Cao Y; Wang DD; Lin PP; Shen L
    Oncotarget; 2014 Aug; 5(16):6594-602. PubMed ID: 25026283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis.
    Ramirez AB; Bhat R; Sahay D; De Angelis C; Thangavel H; Hedayatpour S; Dobrolecki LE; Nardone A; Giuliano M; Nagi C; Rimawi M; Osborne CK; Lewis MT; Stilwell JL; Kaldjian EP; Schiff R; Trivedi MV
    BMC Cancer; 2019 Mar; 19(1):220. PubMed ID: 30871481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.
    Punnoose EA; Atwal S; Liu W; Raja R; Fine BM; Hughes BG; Hicks RJ; Hampton GM; Amler LC; Pirzkall A; Lackner MR
    Clin Cancer Res; 2012 Apr; 18(8):2391-401. PubMed ID: 22492982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.
    Galletti G; Sung MS; Vahdat LT; Shah MA; Santana SM; Altavilla G; Kirby BJ; Giannakakou P
    Lab Chip; 2014 Jan; 14(1):147-56. PubMed ID: 24202699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer.
    Agelaki S; Kalykaki A; Markomanolaki H; Papadaki MA; Kallergi G; Hatzidaki D; Kalbakis K; Mavroudis D; Georgoulias V
    PLoS One; 2015; 10(6):e0123683. PubMed ID: 26083256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
    Jiang T; Zhao J; Zhao C; Li X; Shen J; Zhou J; Ren S; Su C; Zhou C; O'Brien M
    Clin Lung Cancer; 2019 Mar; 20(2):124-133.e2. PubMed ID: 30587399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
    Li TT; Liu H; Li FP; Hu YF; Mou TY; Lin T; Yu J; Zheng L; Li GX
    World J Gastroenterol; 2015 Dec; 21(47):13259-67. PubMed ID: 26715808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer].
    Li Y; Peng Z; Zhang X; Gong J; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1293-1299. PubMed ID: 29178102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques.
    Brouwer A; De Laere B; van Dam PJ; Peeters D; Van Haver J; Sluydts E; El Moussaoui A; Mendelaar P; Kraan J; Peeters M; Van Laere S; Dirix L
    PLoS One; 2019; 14(9):e0220906. PubMed ID: 31483799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer.
    Krishnamurthy S; Bischoff F; Ann Mayer J; Wong K; Pham T; Kuerer H; Lodhi A; Bhattacharyya A; Hall C; Lucci A
    Cancer Med; 2013 Apr; 2(2):226-33. PubMed ID: 23634290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.
    Mishima Y; Matsusaka S; Chin K; Mikuniya M; Minowa S; Takayama T; Shibata H; Kuniyoshi R; Ogura M; Terui Y; Mizunuma N; Hatake K
    Target Oncol; 2017 Jun; 12(3):341-351. PubMed ID: 28508152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.